TRIKAFTA 50mg/25mg/37.5mg + 75mg cpr pell 84 pce
7680677730023
CH-67773
R07AX32
03.99.0.
Active substances:
1 / 3
google
Details
- Product number
- 6777302
- CPT
- -
- Packaging group
- 84 (4 x 21)
- Unit
- Tablette(n)
- Composition
- Filmtablette Morgendosis (elexacaftorum 50 mg / tezacaftorum 25 mg / ivacaftorum 37.5 mg): elexacaftorum 50 mg, tezacaftorum 25 mg, ivacaftorum 37.5 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, E 171, talcum, E 172 (flavum), E 172 (rubrum) pro compresso obducto corresp. natrium 1.34 mg. Filmtablette Abenddosis (ivacaftorum 75 mg): ivacaftorum 75 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 83.6 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 132, cera carnauba, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 0.9 mg.
Articles (1)
Trikafta 50 mg / 25 mg / 37.5 mg, 75 mg, Filmtabletten
Filmtabletten
84 (4 x 21)
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
elexacaftorum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
ivacaftorum
|
75.0 MG | Substance | Wirkstoff (Principe actif) |
|
tezacaftorum
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
ivacaftorum
|
37.5 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
83.6 MG | Substance | HBESI |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
talcum
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 132
|
- | Substance | FIMDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
cera carnauba
|
- | Substance | HNIDK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
lacca
|
- | Substance | HNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
natrium
|
1.34 MG | Substance | HBESI |
|
propylenglycolum
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
ammonii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
0.9 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 14565.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2022
Authorization holder
Vertex Pharmaceuticals (CH) GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 67773
- Drug name
- Trikafta, Filmtabletten
- Galenic form
- TAB
- ATC Code
- R07AX32
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/12/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 03.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRIKAFTA 50mg/25mg/37.5mg + 75mg cpr pell 84 pce
- Description (DE)
- TRIKAFTA 50mg/25mg/37.5mg + 75mg Filmtabl 84 Stk
- Market launch
- 05/01/2022
- Narcotic (BTM)
- No